Treatment of cancer with a semaphorin-4D antibody in combination with an epigenetic… Grant US-11572408-B2 United States of America 07 Feb 2023
Use of semaphorin-4D binding molecules for modulation of blood brain barrier permeability Grant US-11534488-B2 United States of America 27 Dec 2022
Anti-CD100 antibodies and methods for using the same Grant US-11274149-B2 United States of America 15 Mar 2022
Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit… Grant US-11078295-B2 United States of America 03 Aug 2021
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders Grant US-10800853-B2 United States of America 13 Oct 2020
Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to… Grant US-10526414-B2 United States of America 07 Jan 2020
Use of semaphorin-4D binding molecules to promote neurogenesis following stroke Grant US-10494440-B2 United States of America 03 Dec 2019
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders Grant US-10385136-B2 United States of America 20 Aug 2019
Use of semaphorin-4D inhibitory molecules in combination with an immune modulating… Application AU-2014302812-B2 Australia 11 Jul 2019
Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D… Grant US-9828435-B2 United States of America 28 Nov 2017
Anti-CD100 neutralizing antibodies and methods of using the same Grant US-9676840-B2 United States of America 13 Jun 2017
Anti-CD100 antibodies and methods of using the same Grant US-9605055-B2 United States of America 28 Mar 2017
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders Grant US-9598495-B2 United States of America 21 Mar 2017
USE OF SEMAPHORIN-4D INHIBITORY MOLECULES IN COMBINATION WITH AN IMMUNE MODULATING… Application EP-3013350-A4 European Patent Office 22 Feb 2017
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders Grant US-9249227-B2 United States of America 02 Feb 2016
Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases Grant US-9243068-B2 United States of America 26 Jan 2016